Today on Stockhead, Josh Chiat’s got all the big bulk buy news, including the new coking coal rally, and Eddy Sunarto chats to Weebit Nano’s CEO after his company won the ASX semiconductor race to revenue.
But first, to markets!
COMMODITY/FOREX/CRYPTO MARKET PRICES
Gold: US$1,992.62 (+0.15%)
Silver: US$23.67 (+0.20%)
Nickel (3mth): US$16,435/t (-3.28%)
Copper (3mth): US$8,353.50/t (-1.13%)
Oil (WTI): US$76.125 (-1.11%)
Oil (Brent): US$80.13 (-2.23%)
Iron 62pc Fe: US$129.84/t (+0.00%)
AUD/USD: 0.6555 (+0.20%)
Bitcoin: US$37,250 (+1.20%)
WHAT GOT YOU TALKING
Noooooooooooooooooooooooooooo.
Ok, maybe.
Sodium-ion could command half the Chinese domestic #electricvehicle market by 2030, analyst @heppel_george says.
Will this tech kill the #lithium dream?
— Stockhead (@StockheadAU) November 28, 2023
YESTERDAY’S ASX SMALL CAP LEADERS
Here are the best performing ASX small cap stocks:
Swipe or scroll to reveal full table. Click headings to sort:
Romping it in on Tuesday: InteliCare (ASX:ICR), after securing a rather terrific non-binding Memorandum of Understanding (MoU) with Bolton Clarke – hopefully a staging ground for a full-on Strategic Partnership.
ICR is a medtech of sorts, with a fair bit of SaaS and other stuff thrown in. It’s been developing predictive analytics hardware and software for use in the aged care sector.
In this case its MOU partner also happens to be Australia’s largest independent not-for-profit aged care provider, with ICR saying its platform will find a home somewhere across Bolton Clarke’s various sites and services.
What amounts to a pilot project will assess how ICR gels within the Bolton Clarke operating environment and help ICR assess and identify areas of possible enhancement.
The non-bank lender Plenti Group (ASX:PLT) dropped some decent results for the first half of its 2024 (six months to September 30), but it’s entirely possible investors have come for the PLT’s results, but stayed for its shiny new partnership with National Australia Bank, one which actually involves money and integration into the bank’s embrace.
PLT says, the tie-in involves… “initially launching a ‘NAB powered by Plenti’ car and electric vehicle (EV) loan and then making Plenti renewable energy finance available to NAB customers.”
There’s also an equity investment deal – allowing NAB to ‘acquire up to 15% of Plenti’s share capital’ through placements and market purchases and such.
That, in fintech parlance, is commitment.
Imugene (ASX:IMU) – everyone’s fav ‘clinical stage immuno-oncology’ stock – was higher after announcing that its ‘MAST (Metastatic Advanced Solid Tumours) clinical program evaluating the safety and efficacy of novel cancer-killing virus CF33-hNIS (VAXINIA)’, has been given the sought-after “Fast Track Designation (FTD)” from the US Food and Drug Administration (FDA).
The FDA’s FTD for IMU’s Bile Duct Cancer CF33-hNIS (VAXINIA) MAST clinical program is of course great news for the company, according to Imugene CEO and MD Ms Leslie Chong.
TODAY’S ASX SMALL CAP LAGGARDS
Here are the day’s worst performing ASX small cap stocks:
Swipe or scroll to reveal full table. Click headings to sort:
TRADING HALTS
IPD Group (ASX:IPG) – Pending an announcement in relation to a proposed capital raising comprising an institutional placement and pro rata accelerated non-renounceable entitlement offer
Provaris Energy (ASX:PV1) – Pending an announcement regarding a capital raising
LCL Resources (ASX:LCL) – Pending an announcement regarding a capital raising
88 Energy (ASX:88E) – Pending an announcement regarding a capital raising
Cooper Metals (ASX:CPM) – Pending an announcement regarding material exploration results
Euro Manganese (ASX:EMN) – Pending an announcement to the market in relation to a financing transaction, for which the documents are just being signed
The post Rise and Shine: Everything you need to know before the ASX opens appeared first on Stockhead.
+ There are no comments
Add yours